As per Maximize Market research, the Drug-Device Combination Products Market was USD 110.2 Bn in 2022 and is expected to grow at a CAGR of 7.1 percent over the forecast period to reach USD 178.12 Bn by 2029.
Drug-Device Combination Products Market Report Scope and Research Methodology
The Drug-Device Combination Products Market report provides a detailed analysis of the report through market share, market report and competitive benchmarking of the key companies. The bottom-up approach was used to estimate the size of the market. Primary and secondary research methods were used to collect data. Collected data is later analyzed by methods such as SWOT and PESTLE analysis.
The growth of the Drug-Device Combination Products Market is propelled by a rising incidence of persistent health conditions like diabetes, heart disease, cancer, and respiratory disorders, requiring ongoing medical intervention. Also, the growing technological innovation is driving the market growth.
North America held the largest share of the market in 2022 and is expected to grow significantly throughout the forecast period (2023-2029). The rising prevalence of chronic diseases and the ongoing technological advances are driving the growth of the region.
Maximize Market Research provides B2B and B2C research on 6,500 high-growth emerging opportunities and technologies as well as threats to the companies across the Healthcare, Pharmaceuticals, Electronics and Communications, Internet of Things, Food and Beverages, Aerospace and Defense and other manufacturing sectors.
We are pleased to offer you this exciting, new, and entirely free professional resource. Visit our Free Biotechnology & Pharmaceuticals resource center today to browse our selection of 600+ complimentary Biotechnology & Pharmaceuticals magazines, white papers, webinars, podcasts, and more. Get popular titles including: